Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
Follow-Up Questions
What is the price performance of TCLIF stock?
The current price of TCLIF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Theraclion SA?
Theraclion SA belongs to Health Care industry and the sector is Health Care
What is Theraclion SA market cap?
Theraclion SA's current market cap is $0
Is Theraclion SA a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Theraclion SA, including 4 strong buy, 4 buy, 1 hold, 0 sell, and 4 strong sell
